Josh Turek Calls for Legal, Taxed Cannabis in Iowa’s U.S. Senate Race

Josh Turek noticed a cannabis leaf on a man’s hat at an Iowa State University football tailgate. A woman nearby brought the conversation back to pain: she wanted federal marijuana laws changed so she could use gummies at night. In Tom Angell’s September 7 account for Marijuana Moment, the exchange ended with the Democratic U.S. Senate nominee endorsing legalization, regulation and taxation. (S1)

Turek is an Iowa state representative, not a sitting U.S. senator. The distinction matters because the office he is seeking writes federal law, while the office he holds helps determine what Iowa permits. The legislature’s current roster lists him as the Democratic representative for House District 20 in Pottawattamie County. His opponent for the Senate seat is Republican U.S. Rep. Ashley Hinson. (S2, S12)

For a cannabis operator, the election offers more than a familiar argument about whether adults should be allowed to consume the drug. Hinson’s congressional record separates access to financial services from legalization itself. Iowa’s governor has meanwhile approved a narrower expansion of medical access. Those are distinct decisions with different consequences for who can sell, who can buy and who will handle the money. (S5, S6, S7)

“I think it should be legalized and regulated, and let’s tax it.”

— Josh Turek, Iowa state representative and U.S. Senate candidate, as reported by Marijuana Moment (S1)

The medical theme in Turek’s remarks fits a documented part of his biography. His campaign describes a childhood with spina bifida and 21 surgeries before age 12, followed by a career in wheelchair basketball. It also describes his work helping patients obtain wheelchairs and other mobility equipment. These details explain the personal context he brings to access debates; they do not establish the effectiveness of a cannabis product for any particular condition. (S3)

His legislative record supplies firmer evidence of policy intent than a campaign conversation alone. Turek appears among the sponsors of House File 442, introduced in 2023. The proposal combined adult-use retail licensing, changes to criminal penalties and revisions to medical cannabis rules. It included a 10 percent retail excise tax and allocated receipts among community reinvestment, mental health and substance-use prevention, and local public safety. It was a proposal, not an enacted adult-use market. (S4)

The proposal also made regulation an operating obligation. It called for rules on security, labeling, health and safety, advertising, cultivation and testing. Cultivators would track cannabis through wholesale purchase, and licensed businesses would retain transaction records for inspection. Professional licensing boards would be barred from penalizing someone merely for providing services to a retail cannabis establishment. Those provisions show how a legalization bill can reach accountants, equipment suppliers and other businesses around the plant. They are useful questions for a future federal proposal: which activity is protected, what records must be kept and which regulator has authority to examine them? (S4)

That history helps define the limits of the new remarks. A state bill he cosponsored is evidence of support for regulated commerce. It is not a federal bill, and its tax rate cannot be treated as his proposed national rate. The Senate platform reviewed for this article does not set out a detailed federal cannabis tax or licensing system. The specifics of any federal legislation he would introduce remain an open question. (S4, S13)

Hinson voted no when the House passed the Marijuana Opportunity Reinvestment and Expungement Act on April 1, 2022. The clerk recorded a 220-204 vote. That supplies a direct contrast with Turek’s position on federal legalization, without needing to infer her views from party affiliation or campaign rhetoric. The record establishes what she voted on that bill; it does not explain every reason behind her decision. (S5)

Her banking vote went the other way. On April 19, 2021, she supported the SAFE Banking Act, which passed the House 321-101. A description of her as opposing every form of cannabis reform would therefore miss a recorded distinction. Supporting a financial-services bill and supporting a legal adult-use market are different positions, and her two votes demonstrate that difference. (S6)

For businesses, the practical distinction is substantial. A bank account supports payroll and deposits. A lending relationship can finance equipment or a buildout. Neither creates a retail license or establishes who may purchase cannabis. The Government Accountability Office’s newly released banking study describes an industry in which obtaining an account, maintaining it and accessing other financial services remain separate problems. A campaign promise about one should not be read as a solution to all three. (S11)

GAO’s report also prevents an easy shortcut in describing federal policy. It notes the April 2026 rule moving certain FDA-approved marijuana products and marijuana subject to a state medical marijuana license into Schedule III. Other marijuana remains in Schedule I under the framework the report describes. Federal rescheduling therefore cannot be summarized as nationwide adult-use legalization. Turek’s broader position reaches beyond changing a scheduling classification. (S11)

The same report describes financial institutions weighing legal uncertainty, compliance staffing, monitoring costs and payment-network restrictions. Some told GAO that protection from federal penalties could bring them into cannabis banking. Others would require broader changes. That is why the legislative text, rather than the word reform, will determine the business effect of either candidate’s approach. This is an inference from the report’s findings, not a forecast of how Congress will vote. (S11)

The scope of a bill will also determine who benefits first. GAO distinguishes businesses that grow or sell cannabis from ancillary companies supplying equipment or professional services. Some financial institutions serve only the latter. A change that helps a landlord or software provider may leave a cultivator’s borrowing options largely unchanged. The Iowa race puts those differences behind a simple electoral question, but the differences survive the election. (S11)

Gov. Kim Reynolds signed House File 990 on June 2, 2026. The law concerns medical cannabidiol registration and dispensary licensing, including removing the patient residency requirement and permitting up to 10 dispensaries instead of five. A higher statutory ceiling is permission to license more locations; it is not evidence that all the additional stores have opened. The signed document supplies no basis for calling Iowa an adult-use state. (S7)

The distinction between legislative permission and an operating business is visible in the text. The department accepts applications and may license additional dispensaries within the higher limit. Licensing remains an administrative step after the law changes. For a prospective operator, the statute describes an opportunity governed by the medical program, rather than a general invitation to sell to adults. (S7)

Iowa HHS’s August 19 regulatory analysis shows the patient side of that process. It reported 17,741 patients and 524 caregivers participating in the program and proposed rules implementing the residency change. The agency expected qualified Nebraska residents to be the main beneficiaries, while saying it did not anticipate a large influx. Those are the agency’s figures and expectations at the time of the filing, not a September customer forecast. (S8)

The proposed rules also restore veteran eligibility for a $25 patient registration fee rather than the standard $100. HHS said the language had been removed inadvertently during an earlier rules review. Its notice scheduled a September 8 hearing. The notice establishes a proposed change and a procedural date; it does not establish that final rules were adopted at that hearing. (S8)

A separate campaign is asking Iowa to go further. Rob Sand, the Democratic nominee for governor, proposes adult-use regulation through an expanded alcohol-regulatory structure, with licensing for growers, manufacturers, retailers and testing laboratories. His published plan would prioritize small and midsize family farms for cultivation licenses. These are campaign commitments, not rules currently available to an applicant. They also belong to Sand, not Turek. (S9)

Sand’s plan gives the word regulated some concrete boundaries: purchases limited to adults 21 and older, THC limits of 10 milligrams per serving and 100 milligrams per package, child-resistant packaging and restrictions on marketing that appeals to children. It would also prohibit public consumption. The proposal demonstrates that support for legalization can include substantial product and conduct restrictions. It does not resolve how a future legislature would write them. (S9)

In remarks in Dubuque reported on August 26, Sand treated health and nuisance concerns as reasons to regulate rather than dismiss. He argued against imprisoning people simply for using cannabis while acknowledging risks, discussing potency labeling and restrictions intended to protect children. That position complicates a campaign narrative divided neatly between people who think cannabis harmless and people who oppose reform. Legalization advocates can disagree about the products a legal market should contain. (S10)

For Turek, the next substantive test is whether the federal position acquires a legislative design. His state record addresses taxation and licensing; Hinson’s voting record shows that a coalition for banking can differ from one for legalization. Iowa’s enacted medical expansion shows how much narrower an actual change may be than the surrounding debate. These records make the campaign worth following without treating its promises as an operating plan. (S4, S5, S6, S7)

At the tailgate, a question about relief led Turek to a federal policy commitment. The reporting establishes that commitment. It does not establish a bill, a tax rate or a date when the woman who raised the question would see the law change. Those are the next facts the campaign will have to supply. (S1)

Keep Reading

Policy & Compliance

Nebraska Cannabis Wins 7-0 in Court. The Next Bottleneck Is a License

Crista Eggers’s campaign survived the signature challenge to both medical cannabis laws. But proposed fees remain unfinished, current licenses renew every six months, and the September 14 commission meeting is a regulatory milestone, not a promised opening day.

By Cannabis Inc, Editorial Staff·7 min read

Policy & Compliance

Georgia Wants USPS to Deliver Medical Cannabis. The Postal Service's Rulebook Has a Catch

Regulators say April's Schedule III order lets the state's 18 dispensaries ship to 45,000 patients by certified mail, with a vote set for Sept. 30. But USPS Publication 52 still requires a DEA registrant on both ends of a controlled-substance package, and a 2021 rule bars vapes from the mail entirely.

By Cannabis Inc, Editorial Staff·7 min read